[Pathology of the cervix uteri as a consequence of hormonal therapy].
Morphological and functional characteristics are outlined for various types of endocervical hyperplasia attributed to prolonged administration of combined hormonotherapy with progestin-estrogenic and gestagen preparations for endometrial hyperplasia, external and internal endometriosis and myoma uteri. Endocervical hyperplasia belongs to iatrogenic pathology. Terminological issues of hyperplasia and differential diagnosis of atypical microglandular hyperplasia and adenocarcinoma are discussed.
B I
BI
Zheleznov
L S
LS
Ezhova
O A
OA
Mogirevskaia
D000328:Adult; D002584:Cervix Uteri / Q000187:drug effects* / Q000473:pathology; D003937:Diagnosis, Differential; D045166:Estradiol Congeners / Q000009:adverse effects*; D005260:Female; D006801:Humans; D007049:Iatrogenic Disease; D008508:Medication Errors; D008875:Middle Aged; D009092:Mucous Membrane / Q000187:drug effects / Q000473:pathology; D011230:Precancerous Conditions / Q000139:chemically induced / Q000175:diagnosis / Q000473:pathology; D045167:Progesterone Congeners / Q000009:adverse effects*; D002578:Uterine Cervical Dysplasia / Q000139:chemically induced / Q000175:diagnosis / Q000473:pathology; D002583:Uterine Cervical Neoplasms / Q000139:chemically induced / Q000175:diagnosis / Q000473:pathology
D045166:Estradiol Congeners; D045167:Progesterone Congeners
Patologiia sheĭki matki vsledstvie gormonal'noĭ terapii.